Krsnaa Diagnostics KRSNAA
Radiology and pathology services under public-private partnerships (PPP) with state governments, plus its own retail centres
Mapped in 1 theme: Hospitals & Healthcare.
Where Krsnaa Diagnostics sits in the supply chain
Krsnaa Diagnostics appears in 1 supply-chain layer in one theme, Hospitals & Healthcare.
Hospitals & Healthcare › Radiology & imaging
OperatorOther companies in this layer
Revenue and profit
| ₹ Cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 455 | 487 | 620 | 717 | 773 |
| Net profit | 68 | 62 | 57 | 78 | 101 |
Latest-year revenue ₹773 Cr (FY26, company-wide).
Strengths
- Largest PPP diagnostics operator - long contracts with high volumes in government hospitals
- Low-cost model at government-set prices
Risks
- Payment delays from state governments stretch receivables
- Contract renewals and retendering risk
Common questions
What does Krsnaa Diagnostics do?
Radiology and pathology services under public-private partnerships (PPP) with state governments, plus its own retail centres.
Where does Krsnaa Diagnostics sit in the supply chain?
Krsnaa Diagnostics (NSE: KRSNAA) is mapped in 1 supply-chain layer: Radiology & imaging (Hospitals & Healthcare).
Who are Krsnaa Diagnostics' peers?
In the Radiology & imaging layer of Hospitals & Healthcare: Vijaya Diagnostic Centre, Mahajan Imaging & Labs (not NSE-listed), Siemens Healthineers India (not NSE-listed) and Wipro GE Healthcare (not NSE-listed).
What is Krsnaa Diagnostics' market cap and valuation?
As of 6 Nov 2026: market cap ₹1,539 Cr, P/E 15.7x, ROCE 12.7%, ROE 10.9%, dividend yield 0.42%.